COHEN RAYMOND W 4

What Happened
Raymond W. Cohen, a director of RxSight, Inc. (RXST), received an award of 30,864 restricted stock units (RSUs) on June 17, 2026 (transaction code A — award/grant). The filing lists no per-share price or immediate cash value (price shown as N/A). These RSUs represent contingent rights to receive common shares upon vesting, not current ownership of shares.

Key Details

• Transaction date: 2026-06-17 (Form 4 filed 2026-06-18). Filing appears timely (next-business-day filing).
• Grant: 30,864 RSUs; acquisition type: Award/Grant (A); price/value: N/A in the filing.
• Vesting (footnote): 100% of the RSUs vest on the earlier of (i) the one-year anniversary of the June 17, 2026 grant date or (ii) the date of the next annual meeting of stockholders, provided Cohen continues as an Outside Director.
• RSU mechanics (footnote): Each RSU represents a contingent right to receive one share of RxSight common stock once vested.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Exhibit: Exhibit 24 (Power of Attorney) attached to the filing.

Context
This was an equity award, not a purchase or sale — RSUs give future upside only if and when they vest and convert to shares. Such director RSU grants are common compensation for board service and do not by themselves signal insider buying or selling.